| Sep 3 |
LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 20 |
LAVA Therapeutics GAAP EPS of -$0.31 beats by $0.03
|
| Aug 20 |
LAVA Reports Second Quarter 2024 Financial Results and Business Update
|
| Jun 20 |
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
|
| Jun 10 |
LAVA Announces Annual Meeting of Shareholders
|
| May 30 |
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
|
| May 21 |
LAVA Therapeutics GAAP EPS of -$0.02 beats by $0.20, revenue of $6.99M beats by $3.49M
|
| May 21 |
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
|
| May 6 |
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
|
